Arkolith/Insider Trading/ATHA/Form 4

Perceptive Advisors LLC

Director, 10% OwnerAthira Pharma, Inc. (ATHA) · full profile →Form 4 · filed Dec 23, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
2 non-derivative · 7 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 23, 2025Grant(A)989K$6.35$6.3M1.5M
Dec 23, 2025Grant(A)330K$6.35$2.1M330K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 23, 2025Grant(A)5.5M——5.5M
Dec 23, 2025Grant(A)1.2M$6.35$7.5M1.2M
Dec 23, 2025Grant(A)458K$6.35$2.9M458K
Dec 23, 2025Grant(A)3.5M$6.35$22.5M3.5M
Dec 23, 2025Grant(A)3.8M$6.35$24.4M3.8M
Dec 23, 2025Grant(A)1.4M$6.35$8.7M1.4M
Dec 23, 2025Grant(A)1.3M$6.35$8.1M1.3M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001012975-25-000979) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML